Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001638599-17-000642

Options or other derivatives

  • Director acquired 6,410 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Farokhzad Omid · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-06-16 Grant or award : show line 1 in the form Stock Option (Right to Buy) +6,410 $17.47 2027-06-15 6,410 6,410 D
Loading xslF345X03/doc4_4808.xml…